Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. faced a notable stock decline today, contrasting with the broader market. Despite recent losses, the company has shown strong long-term growth and solid financial metrics, including robust operating cash flow and consistent positive quarterly results over the past two and a half years.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. faced a decline in stock value today, reaching an intraday low. However, the company has shown impressive annual growth of 110.19% and a remarkable 328.19% increase over three years, supported by strong financial metrics and a stable market position in the pharmaceuticals sector.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has experienced notable stock performance, rising significantly today and over the past month. The company has shown strong financial metrics, including a high return on equity and consistent profit growth, alongside a competitive dividend yield in the pharmaceuticals sector.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has seen notable stock performance, rising significantly today and over the past week, month, and year. The company has consistently reported positive results for ten consecutive quarters, demonstrating strong financial health and a substantial market capitalization in the pharmaceuticals sector.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has demonstrated strong performance, achieving significant gains over various timeframes. The company has reported positive results for ten consecutive quarters, with impressive operating cash flow and return on equity. Its market capitalization reflects its solid standing in the pharmaceuticals and biotechnology sector.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has shown remarkable performance, achieving significant intraday gains and outperforming the broader market over various time frames. The company has consistently reported positive results for ten consecutive quarters, supported by strong financial metrics, including a high return on equity.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has shown strong performance, achieving an intraday high and significant gains over the past week and month. The company boasts a solid financial position with high operating cash flow and a notable return on equity, reinforcing its status in the pharmaceuticals sector.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. faced significant stock volatility, hitting an intraday low and experiencing notable declines over various time frames. Despite these challenges, the company reported strong operational metrics, including a high return on equity and substantial operating cash flow, within a competitive pharmaceutical sector.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. saw a decline in its stock today, contrasting with the broader market's performance. Despite recent losses over the week and month, the company has shown strong growth over three years and maintains a solid financial position with consistent positive results.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. saw a significant stock decline today, contrasting with the broader market. Over the past week and month, the stock has experienced notable decreases, yet the company has shown strong long-term growth and maintains a solid financial position with consistent positive results and a commitment to shareholder returns.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. faced a notable decline in stock value, contrasting with the modest gain of the China Shanghai Composite. Despite recent challenges, the company has shown resilience with positive long-term performance and strong financial metrics, including a high return on equity and consistent quarterly profits.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. saw a notable stock price increase on May 29, 2026, reaching an intraday high. The company has shown consistent growth, with significant increases over the past three and five years, alongside strong financial metrics and a solid operational foundation.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. faced a significant decline in its stock today, marking an 8.08% decrease over the past week and a 20.36% drop in the last month. Despite these challenges, the company has shown impressive long-term growth and maintains a strong financial position.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. faced a significant stock decline today, contrasting with the broader market's modest gain. Over the past month, the company's stock has dropped considerably, although it has shown strong long-term performance, with a notable annual return and consistent positive financial results.

Sunshine Guojian Pharmaceutical has recently adjusted its evaluation, reflecting strong market performance. The company reported a record operating cash flow of CNY 2,979.1 million and a return on capital employed of 15.87%. Over the past year, it achieved a profit increase of 131.7% and outperformed the broader market significantly.